Ropivacaine recalls

The FDA has published 14 recalls involving Ropivacaine since 2015. The latest was reported on 29 Jul 2026. Most were for sterility. Guardian Pharmacy Services has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls14since 2015

Last 12 months1reported

Class I17% of total

Ongoing4latest 29 Jul 2026

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 1May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 1 0Aug 0 0

Severity split

Class I 1 7%Class II 13 93%Class III 0 0%

Why ropivacaine is recalled

Companies

Brands

Naropin17%
Ropivacaine Hydrochloride17%

By year

202617%
202517%
2023214%
202217%
2018643%
201717%
201617%
201517%

Ongoing ropivacaine recalls

4 active

Reported	Class	Recall	Company	Reason	Where
29 Jul 2026Drug	CLASS II	Naropin (ropivacaine hydrochloride Injection, USP) recalledNaropin	Fresenius Kabi USA	Particulate Matter	Nationwide
14 May 2025Drug	CLASS I	Ropivacaine Hydrochloride Injection, USP, 0.5%, 500 mg per (5mg/mL) recalledRopivacaine Hydrochloride	Amneal Pharmaceuticals	Particulate Matter	Nationwide
7 Jun 2023Drug	CLASS II	Ropivacaine Hydrochloride Injection USP, 0.5%, 150mg recalled by Akorn	Akorn	Potency & Assay	Nationwide
7 Jun 2023Drug	CLASS II	Ropivacaine Hydrochloride Injection USP, 0.2%, 200mg/ (2 mg/mL) Vial recalled	Akorn	Potency & Assay	Nationwide

All ropivacaine recalls, newest first

14 total

Reported	Class	Recall	Company	Reason	Where
29 Jul 2026Drug	CLASS II	Naropin (ropivacaine hydrochloride Injection, USP) recalledNaropin	Fresenius Kabi USA	Particulate Matter	Nationwide
14 May 2025Drug	CLASS I	Ropivacaine Hydrochloride Injection, USP, 0.5%, 500 mg per (5mg/mL) recalledRopivacaine Hydrochloride	Amneal Pharmaceuticals	Particulate Matter	Nationwide
7 Jun 2023Drug	CLASS II	Ropivacaine Hydrochloride Injection USP, 0.5%, 150mg recalled by Akorn	Akorn	Potency & Assay	Nationwide
7 Jun 2023Drug	CLASS II	Ropivacaine Hydrochloride Injection USP, 0.2%, 200mg/ (2 mg/mL) Vial recalled	Akorn	Potency & Assay	Nationwide
27 Jul 2022Drug	CLASS II	Ropivacaine HCl 123 mg (2.46 mg/mL), Clonidine HCl 0.04 mg recalled	Nephron Sterile Compounding Center	Sterility	Nationwide
15 Aug 2018Drug	CLASS II	Ropivacaine HCl 2 mg/mL recalled by Guardian Pharmacy Services	Guardian Pharmacy Services	Sterility	TX
15 Aug 2018Drug	CLASS II	Ropivacaine HCl 2 mg/mL recalled by Guardian Pharmacy Services	Guardian Pharmacy Services	Sterility	TX
15 Aug 2018Drug	CLASS II	Ropivacaine HCl 2 mg/mL recalled by Guardian Pharmacy Services	Guardian Pharmacy Services	Sterility	TX
25 Jul 2018Drug	CLASS II	0.2% ROPivacaine, (Ropivacaine HCL PF, USP 500mg recalled	Avella of Deer Valley Inc. Store 38	Sterility	Nationwide
28 Feb 2018Drug	CLASS II	Ropivacaine HCl Injection in all strengths, all doses recalled	Pharmedium Services	Sterility	Nationwide
28 Feb 2018Drug	CLASS II	Ropivacaine HCl in 0.9% Sodium Chloride in all strengths recalled	Pharmedium Services	Sterility	Nationwide
31 May 2017Drug	CLASS II	Ropivacaine HCl in 0.9% Sodium Chloride all strengths recalled	Advanced Pharma	Packaging Defects	Nationwide
21 Dec 2016Drug	CLASS II	Ropivacaine HCl 0.25% in 0.9% Sodium Chloride, Epidural Use Only recalled	Cantrell Drug	Sterility	Nationwide
16 Sep 2015Drug	CLASS II	Ropivacaine HCl 0.2% in total volume in a Yellow Cassette Res recalled	Pharmedium Services	Sterility	4 states

Should you stop taking Ropivacaine?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.